SA
Go ProLog In
FMS
OverviewIntelligenceChart
Next earnings: Aug 4, 2026 · Before open
Signal
Leaning Bearish1↓
Price
1→
Move→+0.61%Quiet session
Volume
1→
Volume→1.0× avgNormal activity
Technical
1↓
RSI↓RSI 42Momentum negative
PRICE
Prev Close
21.47
Open
21.65
Day Range21.51 – 21.73
21.51
21.73
52W Range20.02 – 30.46
20.02
30.46
15% of range
VOLUME & SIZE
Avg Volume
649.9K
FUNDAMENTALS
P/E Ratio
11.3x
Value territory
EPS (TTM)
—
Div Yield
0.05%
Beta
0.45
Low vol
Performance
1D↑
+0.61%
5D
-2.13%
1M
-5.43%
3M
-11.62%
6M
-7.65%
YTD
-9.32%
1Y↓
-23.94%
Best: 1D (+0.61%)Worst: 1Y (-23.94%)
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev -1% · 26% gross margin
Valuation
CHEAP
P/E 11x vs ~20x sector
Health
MODERATE
CR 1.2 · FCF $3.22/sh
Bullish
Key MetricsTTM
Market Cap$10.04B
Revenue TTM$19.36B
Net Income TTM$944.60M
Free Cash Flow$1.77B
Gross Margin26.0%
Net Margin4.9%
Operating Margin9.7%
Return on Equity7.0%
Return on Assets3.0%
Debt / Equity0.83
Current Ratio1.20
EPS TTM$1.72
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong1 watch3 concern
37/100
Liquidity
1.20Watch
Leverage
0.83Strong
Coverage
5.2xStrong
ROE
7.0%Concern
ROIC
5.5%Concern
Cash
$1.6BConcern
ANALYST COVERAGE17 analysts
HOLD
▲ +29.6%upside to target
Buy
529%
Hold
1165%
Sell
16%
5 Buy (29%)11 Hold (65%)1 Sell (6%)
Full report →
Stock Health
Composite Score
1 of 5 signals bullish
5/10
Technicals
●
RSI RangeRSI 42 — Bearish momentum
✗
Volume
●
Volume FlowAccumulation — institutional buying
✓
Fundamentals
●
Last EarningsMissed estimates
✗
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 1.20
~
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBEARISH
Technicals →

Trend

▼ DowntrendDeath Cross · 50D trails 200D by 6.1%

-4.0% vs SMA 50 · -9.9% vs SMA 200

Momentum

RSI42.1
Momentum fading
MACD-0.33
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$30.46+41.0%
EMA 200
$24.17+11.9%
EMA 50
$22.45+3.9%
Current
$21.60
52W Low
$20.02-7.3%
52-Week RangeNear 52-week low
$20.0215th %ile$30.46
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:7
Dist days:4
Edge:+3 acc
Volume Context
Avg Vol (50D)645K
Recent Vol (5D)
1.0M+56%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 10 analysts
Full estimates →
Analyst revisions:EPS↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$19.6B
$19.1B–$20.1B
—$1.94—
±8%
High10
FY2026(current)
$19.7B
$19.6B–$19.8B
▲ +0.6%$2.03▲ +4.7%
±6%
High9
FY2027
$20.4B
$20.2B–$20.6B
▲ +3.4%$2.19▲ +8.0%
±7%
High10
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryFMS
Last 8Q
+8.6%avg beat
Beat 6 of 8 quartersMissed 1↑ Estimates rising
—
Q3'24
+18%
Q4'24
+17%
Q1'25
+2%
Q2'25
+4%
Q3'25
+8%
Q4'25
+28%
Q1'26
-10%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Goldman SachsNeutral
Jan 20
DOWNGRADE
UBSSell → Underperform
Oct 15
DOWNGRADE
UBSSell
Sep 2
DOWNGRADE
JefferiesUnderperform
Jan 2
DOWNGRADE
Financials
Dividends3.77% yield
+17.7% avg annual growth
Annual Yield3.77%
Annual Div.$0.8716
Est. Annual / Share$0.87
FrequencyAnnual
Q2'19
Q3'20
Q2'21
Q2'22
Q2'23
Q2'24
Q2'25
Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
PZENA INVESTMENT MANAGEMENT LLC
15.1M▲
2
FIDUCIARY MANAGEMENT INC /WI/
4.5M▼
3
DODGE & COX
3.8M—
4
MORGAN STANLEY
2.5M▼
5
MILLENNIUM MANAGEMENT LLC
1.6M▲
6
BRANDES INVESTMENT PARTNERS, LP
1.6M▲
7
TODD ASSET MANAGEMENT LLC
1.3M▲
8
GOLDMAN SACHS GROUP INC
818K▲
News & Activity

FMS News

20 articles · 4h ago

About

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.

CEO
Rice Powell
Country
Germany
Website
freseniusmedicalcare.com ↗
Wolfgang KummerleSenior Vice President - Quality Management International
Glenn SlaterSenior Vice President of Manufacturing and Supply Chain Operations
Joachim WeithSenior Vice President of Corporate Communications & Governmental Affairs
Peers— —(7 companies)
Screen sector →
SymbolPriceDay %Mkt Cap↓P/ERev GrwMarginELO
FMS◀
$21.60+0.61%$11.7B10.8+151.1%498.3%1500
TSM
$404.35-3.20%$2.1T30.5+3296.8%4510.0%1500
BABA
$132.58-6.05%$307.9B20.7-44.8%1012.0%1500
HSBC
$88.38-2.58%$303.7B13.6+318.8%1510.7%1500
NVS
$148.08-1.13%$282.6B21.0+597.3%2564.4%1500
AZN
$181.58-1.83%$281.6B26.9+862.9%1745.9%1500
RY
$183.40-0.23%$256.1B16.8+213.3%1482.4%1500
Sector avg—-2.06%—20.0+770.8%1903.4%1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance